SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

The Boeing Co. is an aerospace company, which engages in the manufacture of commercial jetliners and defense, space, and security systems. It operates through the following segments: Commercial Airplanes (BCA), Defense, Space and Security (BDS), and Global Services (BGS). The Commercial Airplanes segment includes the development, production, and market of commercial jet aircraft and provides fleet support services, principally to the commercial airline industry worldwide. The Defense, Space and Security segment refers to the research, development, production and modification of manned and unmanned military aircraft and weapons systems for global strike, including fighter and combat rotorcraft aircraft and missile systems, global mobility, including tanker, rotorcraft and tilt-rotor aircraft, and airborne surveillance and reconnaissance, including command and control, battle management and airborne anti-submarine aircraft. The Global Services segment provides services to commercial and defense customers. The company was founded by William Edward Boeing on July 15, 1916, and is headquartered in Arlington, VA.

Boeing Co.

Boeing Co

A 737 MAX software glitch has prompted FAA scrutiny and a delay to 737 MAX 10 certification, weighing on Boeing shares. Traders disagree on whether the issue is an old, manageable problem or a serious setback that could prolong certification and delivery delays, amid broader concerns about Boeings execution.

Kodiak Sciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of therapeutics for retinal diseases. Its product pipeline includes KSI-301 for wet AMD, KSI-301 for diabetic eye disease, KSI-501 for DME and uveitis, KSI-201 for resistant wet AMD, and KSI-401 for dry AMD. The company was founded by Stephen A. Charles and Victor Perlroth in 2009 and is headquartered in Palo Alto, CA.

Kodiak Sciences Inc

Kodiaks shares surged after positive Phase 3 DAYBREAK results in wet AMD: both candidates met primary goals, and Zenkuda showed potential for longer intervals between treatments; the company plans an FDA filing for Zenkuda. Traders celebrated the clinical milestone and a possible short squeeze, while others questioned the valuation, competitive edge, and risk of future dilution given Kodiaks precommercial status.

Summit Therapeutics, Inc. is a biopharmaceutical company, that focuses on the discovery, development, and commercialization of patient, physician, caregiver, and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Miami, FL.

Summit Therapeutics Inc

AstraZenecas strategic equity investment and clinical collaboration around ivonescimab are driving attention, with traders welcoming the funding and pharma backing while debating whether it signals broader strategic interest. Some caution that the deal is an investmentnot an acquisitionand that buyout and short-squeeze expectations remain speculative.

Navitas Semiconductor Corp. engages in the development of ultra-efficient gallium nitride (GaN) semiconductors. Its GaN power ICs integrate GaN power with drive, control and protection to enable charging, power density, and energy savings for mobile, consumer, enterprise, eMobility and new energy markets. The company was founded by Daniel Kinzer, Nick Fichtenbaum, Gene Sheridan, and Jason Zhang on August 12, 2020 and is headquartered in Torrance, CA.

Navitas Semiconductor Corp

Navitas selection for a U.S. Army program to develop ultra-high-voltage silicon-carbide technology is driving attention, with traders viewing the award as validation of its technology and speculating about a short squeeze. Others caution that it is a prototype-development project with undisclosed financial terms, so the immediate revenue impact is unclear, and some expect the initial pop to fade.

Fair Isaac Corp. engages in the provision of decision management solutions. It operates through the Software and Scores segments. The Software segment includes pre-configured analytic and decision management solutions designed for a specific type of business need or process. The Scores segment focuses on business-to-business scoring solutions and services, business-to-consumer scoring solutions and services including myFICO solutions for consumers and associated professional services. The company was founded by Bill Fair and Earl Isaac in 1956 and is headquartered in San Jose, CA.

Fair Isaac Corp.

Fair, Isaac Corp.

FHFAs move to let Fannie Mae and Freddie Mac accept VantageScore alongside FICO is driving concern that cheaper competition could erode FICOs longstanding mortgage-scoring advantage. Traders are split between viewing the change as a serious threat to pricing power and treating the selloff as an overreaction given FICOs entrenched business.

Zebec's integrated products - real time payroll apps, on-chain payments infrastructure and networked DePIN - serve companies of all sizes, merchants and individuals and help transcend the boundaries of traditional banking and diminish the role of financial intermediaries.

Zebec Network

ZBCN is drawing attention amid a modest price rebound and ongoing debate over whether Zebecs payroll, card and payments partnerships will translate into sustained token demand. Bulls point to expanding adoption, including enterprise payroll activity on Stellar, while skeptics say the token has lagged despite partnership announcements and want clearer evidence of growing usage and volume.

Red Cat Holdings, Inc. provides products, services and solutions to the drone industry. It also engages in the provision of distributed data storage, analytics and services for the drone industry.The firm product include Dronebox, which is a blockchain technology that records, stores and analyzes flight data and information from a drone. It operates through the Enterprise Segment. The Enterprise Segment will focus on developing a hardware enabled software platform of services and solutions to government and commercial enterprises and the military. The company was founded by Jeffrey M. Thompson in February 1984 and is headquartered in San Juan, Puerto Rico.

Red Cat Holdings Inc

Red Cats steep share decline is drawing attention amid concerns that it has not secured meaningful new orders, is missing revenue expectations, and was not selected for a later stage of the Pentagons Drone Dominance process. Many traders criticize managements credibility and spending on autonomous boats before sales are demonstrated, while some bulls see long-term potential in its defense drones and boats and point to possible future contracts.

iShares Trust - iShares 20+ Year Treasury Bond ETF

iShares 20+ Year Treasury Bond ETF

TLT is under pressure as Treasury yields surge amid persistent inflation concerns, expectations for higher-for-longer rates, and worries about government deficits; traders also point to higher oil prices as an inflation risk. The discussion is largely bearish, though some investors see the selloff as an oversold buying opportunity and expect a rebound if yields turn lower.

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

NVAXs sharp move on elevated volume and a push through recent resistance has traders discussing institutional buying and a potential short squeeze, with some attributing strength to biotech-sector momentum. The community is also speculating about future Matrix-M oncology or partnership news and Sanofis combo-vaccine progress, though no new company catalyst is confirmed in the discussion.

Chainlink is the industry-standard decentralized oracle network that solves the "oracle problem" by connecting smart contracts with real-world data. Blockchains cannot access external information on their own, so Chainlink acts as a secure bridge, enabling smart contracts to react to real-world events using verified, tamper-proof data. It is widely considered one of the first decentralized oracle networks and is the market leader in bringing off-chain data on-chain.  The platform operates through a decentralized network of nodes that fetch, validate, and deliver data to smart contracts. When a contract requests information like a stock price, a committee of independent nodes retrieves and aggregates the data to reach consensus, then delivers a single trustworthy answer. Chainlink offers a suite of services including Data Feeds for asset prices, CCIP for cross-chain token transfers and messaging, Automation for triggering smart contract functions, and Proof of Reserve for verifying asset collateralization.  Chainlink has established itself as critical infrastructure for both DeFi and institutional adoption, with partnerships including Swift, Euroclear, Mastercard, UBS, ANZ, Fidelity International, and J.P. Morgan. Its institutional products include the Chainlink Runtime Environment for tokenized asset workflows, Confidential Compute for privacy-preserving computation, and the Automated Compliance Engine for embedding regulatory rules into smart contracts.  The LINK token is the native asset used to pay node operators for services, fund subscription accounts, and incentivize network security through staking. Node operators stake LINK as collateral, which can be slashed if they provide inaccurate data. Chainlink was co-founded in 2017 by Sergey Nazarov and Steve Ellis, who co-authored the white paper with Ari Juels, and raised $32 million in its September 2017 ICO.

ChainLink

LINKs sharp rally and attempted breakout are driving attention, with bullish traders pointing to Chainlinks institutional and tokenization pushincluding CCIP 2.0 and integrationsalongside broader crypto momentum. Others view the move as a short-lived pump, question whether adoption translates into value for the token, and warn that LINK may remain tied to Bitcoins direction.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

CareDx (CDNA) Stock Jumps 13.0%: Will It Continue to Soar?

CareDx (CDNA) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

These Stocks are Refusing to Cool Off

The closing bell is shaping up to be anything but quiet for these names that stand out as the session heads toward the finish. Greenland Energy Company (NASDAQ:GLND), NeOnc Technologies Holdings (NASDAQ:NTHI), GRAIL (NASDAQ:GRAL), Warby Parker (NYSE:WRBY), Montauk Renewables (NASDAQ:MNTK), Ginkgo Bioworks Holdings (NYSE:DNA), and CareDx (NASDAQ:CDNA).

Thursday's ETF Movers: ARKG, TAN

In trading on Thursday, the ARK Genomic Revolution ETF is outperforming other ETFs, up about 2.6% on the day. Components of that ETF showing particular strength include shares of Caredx, up about 13.5% and shares of Twist Bioscience, up about 10.6% on the day.

And underperform...

Zacks.com featured highlights include CareDx, Ciena, Celestica, Materion and MACOM Technology Solutions

CareDx, Ciena, Celestica, Materion and MACOM Technology Solutions pass a screen focused on efficiency measures and earnings surprises.

Medicare Lab Fee Changes Impact BillionToOne, CareDx Differently

CMS aligns 2027 clinical lab fees with private payors to save $1 billion, yielding positive updates for CareDx and BillionToOne tests.read more...

5 Top-Ranked High-Efficiency Stocks With Strong Profit Potential

Five stocks stand out for high efficiency, with strong receivables, asset, inventory and operating margin metrics.

4 Healthcare Stocks to Play Safe as Fed Gears Up for Rate Hike

AMGN, BHC, CDNA and CNC offer defensive healthcare plays as inflation climbs and the Fed readies for a possible rate hike.

Oil Surge Continues on Escalating Middle East Crisis: 4 Defensive Picks

COCO, CHEF, ASMB and CDNA stand out as four defensive picks amid volatility induced by rising oil prices and Middle East tensions.

Are Medical Stocks Lagging  CareDx (CDNA) This Year?

Here is how CareDx (CDNA) and Concentra Group (CON) have performed compared to their sector so far this year.

CareDx (CDNA) is a Great Momentum Stock: Should You Buy?

Does CareDx (CDNA) have what it takes to be a top stock pick for momentum investors? Let's find out.

CareDx, Inc. operates as a transplant diagnostics company, which discovers, develops and commercializes diagnostic solutions. Its products include AlloMap, AlloSure and Laboratory products. The company was founded on December 21, 1998 and is headquartered in Brisbane, CA.

Caredx Inc

SNOW, CDNA Stocks Hit Fresh 52-Week Highs – What’s Driving Investor Optimism Today?

Equity

Neutral Sentiment

Adding risk (buying more)

Trimming/taking profits

Rotating into safer assets

Staying the course, no changes

We&#39;re about to enter Q4 - how are you positioning your portfolio for the rest of the year?

Stocktwits

We're about to enter Q4 - how are you positioning your portfolio for the rest of the year?

CDNA Caredx Inc